Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 82.20 ▼ -0.09 (-0.11%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Merck & Company (New) | MRK | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.66 | -0.8% | 82.29 | 83.45 | 82.0164 | 82.91 | 82.95 | 00:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 66,304 | 10,152,269 | $ 82.4253 | $ 836.8M | 10.95M | 52.83 - 83.45 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:40:48 | 30 | $82.29 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Merck & Company (New) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 212.41B | 2.58B | $ 6.22B | 2.34 | 35.40 | 2.69B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.20 | 2.67% | 03/14/2019 | 211.77k | 116.90% |
Merck & Company (New) News
UPS to Test In-Home Vaccine Service in U.S. -Reuters Dow Jones News • Fri Mar 22, 2019 10:03 AM (3 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Wed Mar 20, 2019 6:51 PM (4 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Wed Mar 20, 2019 6:51 PM (4 days ago)
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) • Wed Mar 20, 2019 6:44 PM (4 days ago)
BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering GlobeNewswire Inc. • 
• Wed Mar 20, 2019 4:05 PM (4 days ago)
• Wed Mar 20, 2019 4:05 PM (4 days ago)Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug Development Business Wire • Wed Mar 20, 2019 9:00 AM (5 days ago)
Merck, NGM Bio Extend Therapeutics Collaboration to 2022 Dow Jones News • Wed Mar 20, 2019 8:01 AM (5 days ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 81.5 | 83.45 | 80.8 | 81.8843 | 9M | 17M | 12M | 0.79 | 0.97% |
| 1 Month | 79.77 | 83.45 | 79.05 | 81.3219 | 7M | 17M | 10M | 2.52 | 3.16% |
| 3 Months | 75.88 | 83.45 | 72.05 | 77.4178 | 7M | 21M | 11M | 6.41 | 8.45% |
| 6 Months | 70.91 | 83.45 | 66.1 | 75.4260 | 4M | 32M | 12M | 11.38 | 16.05% |
| 1 Year | 54.32 | 83.45 | 52.83 | 69.2860 | 4M | 32M | 10M | 27.97 | 51.49% |
| 3 Years | 53.12 | 83.45 | 52.44 | 63.5161 | 3M | 69M | 9M | 29.17 | 54.91% |
| 5 Years | 56.21 | 83.45 | 45.69 | 60.5644 | 3M | 69M | 10M | 26.08 | 46.40% |
Merck & Company (New) Description
| Merck & Co Inc is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. |
